Medichem, S.A.

Yesterday, the Council of the European Union formally adopted the new Urban Waste Water Treatment Directive (UWWTD), with support from 23 member states. Notably, however, 15 countries expressed concerns about the potential impact on #medicine availability—a critical issue for millions of European #patients and the #competitiveness of the EU’s healthcare sector. The UWWTD introduces an Extended Producer Responsibility (EPR) system, placing a significant financial obligation on pharmaceutical and cosmetics companies to cover at least 80% of costs associated with advanced wastewater treatment. While this move aims to strengthen environmental standards, it raises significant challenges for the healthcare sector: ▶️ #Generics make up 7 out of 10 dispensed medicines in Europe and represent 9 out of 10 critical treatments. These medicines provide #affordable, essential treatments for conditions like cardiovascular diseases, cancer, diabetes, mental health issues, and infections. Increased production costs risk severe impacts on patient care by disrupting access to these vital medicines. ▶️ The pharmaceutical industry already faces inflationary pressures, rising costs in energy, labor, materials, and ongoing supply chain challenges due to geopolitical issues. Adding UWWTD costs could lead to critical #shortages across Europe, affecting millions who need daily treatment. At Medichem, our commitment is clear: to provide accessible, #high-quality, and #sustainable medicines to patients who need treatment. Since our founding half a century ago, we have consistently prioritized environmental #responsibility, operational #excellence, and patient health. Now, addressing these regulatory challenges is essential to safeguard #accessibility. To achieve this, we advocate for sustainable pharmaceutical policies across Europe. A balanced approach in EU policies that encourages domestic production of medicinal products and active ingredients can strengthen supply chains, reduce dependency on external sources, prevent critical medicine shortages, and uphold the highest standards in generic medicines. Medicines for Europe https://lnkd.in/dRif9khy.

For over fifty years, Medichem has dedicated itself to improving health worldwide by making high-quality medicines #accessible to diverse communities. Now, as we adapt to an evolving global landscape, we’re taking this commitment a step further—recognizing that caring for health also means protecting our planet. Our newly released #Sustainability #Manifesto outlines our #vision to integrate environmental responsibility into every level of our operations, ensuring that each product and process reflects our dedication to #quality, transparency, and sustainability. For our #partners: ✅ Medichem is committed to providing high-quality medicines while upholding rigorous environmental standards. ✅ As a vertically integrated company, we control every step, ensuring a reliable supply that meets today’s demands for ethical and sustainable practices. ✅Our team of 400+ spans the USA, Malta, and China, serving over 600 clients in 60+ countries with #solutions that align with our shared #responsibility toward a healthier planet. Learn more about our sustainable journey and the steps we're taking to create a lasting #impact. https://lnkd.in/dCWrFsWW

Excited to share some remarkable milestones from Medichem, a #European pharma company making a significant #impact in the global #generics industry. Key Highlights: ☑️ Founded in 1972, Medichem boasts over 50 years of industry expertise ☑️ A talented team of 450+ professionals dedicated to pharmaceutical innovation ☑️ Global reach spanning 60+ countries with 600+ satisfied customers worldwide ☑️ Commitment to progress: 10% of turnover invested in R&DOur Specialties: • Generic Active Principle Ingredients (APIs) • Finished Dosage Forms (FDFs) • #Chlorhexidine products Medichem's vertically integrated model ensures the highest standards of quality and operational excellence. We're proud to contribute to improving patient #access to medicines across the globe. #Innovation is in our DNA: ☑️ 20 ongoing R&D projects ☑️ 80 patents and patent applications ☑️ Strategic #manufacturing facilities enabling first-to-market opportunities From our roots in Spain to our global presence, Medichem remains committed to contributing to the future of health. We're always eager to connect with fellow industry professionals and potential partners! Learn more about our commitment to #quality, innovation, and global healthcare at Medichem: https://lnkd.in/dZq5pDwa

What a great #CPhI2024! CPhI 2024 has come to a close, and we are proud to say it was a success for Medichem. It’s been a fantastic opportunity to reconnect in person with our customers and established valuable new contacts. The exhibition was not only fruitful but also an important step towards strengthening our community. We had meaningful conversations, which will help us drive future collaborations forward. We want to extend our deepest thanks to our amazing customers, partners, and our dedicated team 🙌. Your support, collaboration, and hard work made all the difference. #CPHIMilan #AtTheHeartOfPharma

Yesterday marked the kickoff of #CPhi2024 bringing together industry leaders and professionals for an exciting event. At Medichem, we’ve had an inspiring first day engaging with industry leaders and partners, A big thank you to everyone who stopped by to visit us today! We can't wait to see you tomorrow for more valuable insights and collaborations as we continue our mission to provide high-quality generics and Chlorhexidine products to patients worldwide. Come and meet us at booth 10F42 – Let’s share a moment and explore new opportunities together!

En Medichem, estamos orgullosos y orgullosas de haber participado nuevamente en la Oncotrail, organizada por la Fundació Oncolliga Girona este fin de semana, una carrera solidaria para recaudar fondos en apoyo a la investigación contra el cáncer. Cada paso representa un avance hacia la detección precoz y tratamientos más eficaces. Esta participación nos ha permitido unirnos como equipo y contribuir a una causa tan importante. Una vez más, gracias a todos/as los/as organizadores/as, al equipo que ha participado en la Oncotrail y a los/as compañeros/as que han apoyado y acompañado al equipo. Shaila Pou, Jordi Cobos, Mireia Guiu Miralpeix, Jairo Montes, Riccardo Geraci, Martí Blaya, Iteng Ng Choi, Nina Casanova González, Jaume Cortiñas Costa, David Marin #equipoMedichem #Oncotrail2024 #Cáncer #ImpactoPositivo

The countdown has begun... Only a few days left until we meet you at CPHI Milan! We’re excited to reconnect with our valued partners and colleagues from the global pharmaceutical market. As a vertically integrated pharma company with nearly 50 years of experience, we develop and manufacture APIs and FDFs for the global generics industry. Our portfolio includes 45 APIs and 20 FDFs, and we’re proud to lead in #Chlorhexidine products. Visit us at Hall 10, Booth F42 to learn more about our commitment to quality, operational excellence, and environmental responsibility 🌍 Looking forward to seeing you there!

We are excited to share the latest milestones of our new #injectables plant, Medichem Solutions, located in the Technology Park of Asturias, in Llanera. We have successfully completed the FAT (Factory Acceptance Test) for the fill and finish machines dedicated to vials, bags, and prefilled syringes (PFS). These tests are crucial to ensure that all equipment operates correctly prior to shipment and installation. In the coming weeks, FAT tests will be conducted for the Autoclave, Freeze Dryer, and Water Treatment Systems, marking the final phase of this process. Our target is to have all machinery installed by the end of this year. Additionally, Infrastructure work continues to advance, with the installation of drainage systems, along with improvements to the roof and exterior façade. We're making great progress and excited for what's ahead! Contact our team if you are interestesed in fill&finish capabilities in a #European state-of-the-art injectables plant. https://lnkd.in/d3HJRGXJ

The Future of Pharma Manufacturing 🗓️ Tuesday, October 8, 2024 🕚 11:00 AM - 11:30 AM (Europe/Madrid) 📍 Hall 5 - Stand 5B49 💡 Topic: Manufacturing 5.0 Join Elisabeth Stampa in an insightful keynote session on the future of pharmaceutical manufacturing. Discover the latest trends, sustainability initiatives, and the transformative impact of Industry 5.0. #PharmaManufacturing #Industry50 #Sustainability #PharmaInnovation #FutureOfManufacturing https://lnkd.in/dSHfmxcR

We are excited to share our 2023 #Sustainability Report, marking our company’s second update. This report highlights our continued efforts to make a #positiveimpact on our environment, local communities, employees and, the clients we serve.   Our sustainability strategy is anchored in four key pillars: ✅ Ethical Business Practices – Ensuring integrity in every decision we make. ✅ Environmental Stewardship – Reducing our environmental footprint and fostering a greener future. ✅ Social Responsibility – Supporting our communities and promoting social well-being. ✅ HealthCare – Innovating with a focus on sustainable healthcare solutions. These pillars guide our actions and reflect our mission to integrate sustainability into every facet of our operations. Our 2023 report showcases tangible progress, from reducing emissions to enhancing community outreach programs. We're committed to driving positive change in our industry and beyond, ensuring that our growth contributes to a more sustainable and responsible world. https://lnkd.in/d2BpRnZq